Manulife (Manufacturers Life Insurance)
ABCL icon

Manulife (Manufacturers Life Insurance)’s AbCellera Biologics ABCL Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-76,082
Closed -$574K – 2960
2023
Q1 		$574K Hold
76,082
– – ﹤0.01% 1928
2022
Q4 		$771K Buy
76,082
+75
+0.1% +$866 ﹤0.01% 1740
2022
Q3 		$752K Sell
76,007
-1,391
-2% -$15.3K ﹤0.01% 1738
2022
Q2 		$824K Buy
+77,398
New +$655K ﹤0.01% 1738

Other funds holding ABCL

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ABCL Position: Q2 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of AbCellera Biologics (ABCL) in Q2 2023, closing a stake of 76,082 shares — an estimated $574K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ABCL in Q2 2022 and held it in 4 quarters. The position peaked at $824K in Q2 2022. 170 funds tracked by Wall St. Rank hold ABCL as of Q2 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining AbCellera Biologics position as of Q2 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 76,082 AbCellera Biologics shares in Q2 2023, an estimated $574K.
  • Manulife (Manufacturers Life Insurance) first reported a position in AbCellera Biologics in Q2 2022 and held it in 4 quarters.
  • Manulife (Manufacturers Life Insurance)'s AbCellera Biologics position peaked at $824K in Q2 2022.
  • 170 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2023, filed 11 Aug 2023.